
Validea's guru fundamental report rates Microsoft (MSFT) at 86% using its Warren Buffett-inspired 'Patient Investor' model, indicating strong alignment with criteria for predictable profitability, low debt, and reasonable valuation. This positions the large-cap growth stock as a compelling long-term prospect, passing nearly all fundamental tests except for 'Initial Rate of Return', suggesting significant interest for value-oriented institutional investors.
Microsoft (MSFT) scores an 86% rating from Validea's 'Patient Investor' model, which is based on the investment strategy of Warren Buffett. This score, considered indicative of strong interest, suggests the company aligns well with criteria favoring firms with predictable long-term profitability, low debt, and reasonable valuations. The analysis highlights Microsoft's fundamental strength, as it passes key tests for earnings predictability, debt service, return on equity, return on total capital, free cash flow, and effective use of retained earnings, including share repurchases. However, the report indicates a single point of weakness: the stock fails the 'Initial Rate of Return' criterion. This specific failure suggests that, while the company's underlying business is robust and its 'Expected Return' is positive, its current stock price may not offer the immediate margin of safety or value-based entry point that the strategy typically seeks.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment